Key Points
JBS missed EPS by 17.22% with $0.20 actual versus $0.2416 expected.
Revenue beat narrowly at $21.61B versus $21.53B estimate, up 0.36%.
Stock declined 3.8% post-earnings to $14.69, down 17.21% over one month.
Earnings miss breaks streak of beats; margin compression signals profitability challenges.
JBS N.V. reported mixed earnings results on May 12, 2026, missing earnings per share expectations while narrowly beating revenue forecasts. The protein and food company posted earnings of $0.20 per share, falling short of the $0.2416 estimate by 17.22%. Revenue came in at $21.61 billion, slightly exceeding the $21.53 billion forecast by 0.36%. The earnings miss marks a notable shift from JBS’s recent track record of consistent beats. The stock declined 3.8% immediately following the announcement, reflecting investor disappointment with the earnings performance.
JBS Earnings Results: Miss on Profitability
JBS N.V. delivered disappointing earnings results that fell short of Wall Street expectations. The company reported $0.20 earnings per share, missing the consensus estimate of $0.2416 by a significant 17.22%. This represents a sharp decline from the previous quarter’s $0.39 EPS, showing deteriorating profitability quarter-over-quarter.
Earnings Per Share Decline
The earnings miss is particularly concerning given JBS’s recent performance. In the prior quarter (Q1 2026), the company beat EPS estimates with $0.39 actual versus $0.322 expected. The current quarter’s $0.20 result signals weakening operational efficiency and margin compression. This marks the first earnings miss in the last four quarters, breaking a streak of consistent outperformance.
Profitability Pressure
The significant EPS decline suggests JBS faced cost pressures or lower margins in the quarter. Despite maintaining strong revenue growth, the company struggled to convert top-line gains into bottom-line profits. This profitability squeeze may reflect higher input costs, competitive pricing pressures, or operational challenges in the protein processing business.
Revenue Beat Provides Limited Relief
While JBS missed on earnings, the company delivered a narrow revenue beat that provided some positive news. Revenue reached $21.61 billion, exceeding the $21.53 billion estimate by $78 million or 0.36%. However, this modest beat offers limited comfort given the significant earnings miss.
Revenue Growth Trajectory
JBS’s revenue performance shows solid top-line momentum. The $21.61 billion result represents growth from the prior quarter’s $23.06 billion, though this reflects normal seasonal variation in the food processing industry. Year-over-year, the company continues to demonstrate revenue resilience in a competitive market.
Revenue Quality Concerns
The disconnect between revenue growth and earnings decline raises questions about revenue quality. Strong revenue growth coupled with declining earnings suggests margin compression. The company may be sacrificing profitability to maintain market share or facing structural cost challenges that offset pricing power.
Market Reaction and Stock Performance
Investors reacted negatively to JBS’s mixed earnings report, sending the stock lower in immediate post-earnings trading. The stock declined 3.8% on the day, closing at $14.69 from the previous close of $15.27. This selloff reflects disappointment with the earnings miss and concerns about profitability trends.
Technical Deterioration
The stock’s weakness extends beyond the earnings day. Over the past month, JBS has declined 17.21%, significantly underperforming broader market expectations. The 52-week range of $12.37 to $18.65 shows the stock trading near the lower end, suggesting investor sentiment has soured considerably.
Valuation Remains Attractive
Despite the selloff, JBS trades at a P/E ratio of 7.78, which remains attractive relative to packaged foods peers. The stock’s market cap of $32.6 billion and low valuation multiple suggest the market may be pricing in continued earnings pressure. Meyka AI rates JBS with a grade of B+, indicating the company retains fundamental strength despite near-term challenges.
Quarterly Performance Comparison and Outlook
JBS’s current quarter results represent a notable deterioration compared to recent quarters, raising questions about sustainability. The earnings miss breaks a streak of consistent beats and signals potential headwinds ahead.
Recent Quarter Performance
Looking at the last four quarters, JBS has demonstrated mixed results. Q1 2026 showed strong $0.39 EPS beating $0.322 estimates. Q3 2025 delivered $0.52 EPS versus $0.507 expected. Q2 2025 posted $0.53 EPS beating $0.4854 estimates. The current quarter’s $0.20 EPS represents the weakest performance in this period, suggesting operational challenges or seasonal weakness.
Forward Guidance Implications
Without specific forward guidance, investors must assess JBS’s trajectory based on current trends. The earnings miss and margin compression suggest caution for near-term performance. However, the company’s strong revenue beat and consistent revenue generation provide some foundation for recovery. Analyst consensus remains constructive with 4 Buy ratings and 1 Hold, though the earnings miss may prompt rating reviews.
Final Thoughts
JBS N.V. missed EPS expectations by 17.22% while slightly beating revenue forecasts, with earnings dropping from $0.39 to $0.20 per share. This signals margin compression and profitability concerns despite revenue growth. The stock fell 3.8% post-earnings as investors worry about earnings quality. Although JBS trades at an attractive 7.78x P/E valuation with a B+ grade, the earnings miss breaks its consistent beat streak and raises operational efficiency questions. Investors should watch whether this weakness is temporary or signals a structural profitability decline.
FAQs
Did JBS beat or miss earnings estimates?
JBS missed EPS estimates significantly at $0.20 versus $0.2416 expected (17.22% miss), but revenue slightly beat at $21.61B versus $21.53B estimated (0.36% beat).
How does this quarter compare to previous quarters?
This quarter is the weakest in four quarters with $0.20 EPS, compared to $0.39 prior quarter, $0.52 in Q3 2025, and $0.53 in Q2 2025, indicating deteriorating profitability.
What caused the earnings miss?
Margin compression likely drove the miss. Despite revenue growth, JBS faced higher input costs, competitive pricing pressures, or operational challenges that significantly reduced profitability.
How did the stock react to earnings?
JBS stock fell 3.8% post-earnings to $14.69 and declined 17.21% over the past month, trading near its 52-week low of $12.37, reflecting investor concerns about profitability.
What is the Meyka AI grade for JBS?
Meyka AI rates JBS B+, indicating solid fundamentals despite near-term challenges. The company trades at an attractive 7.78x P/E with analyst consensus of 4 Buy and 1 Hold.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)